What top creators are saying about Ultragenyx Pharmaceutical Inc.(RARE)

A pharmaceutical company with a key drug study for osteogenesis imperfecta.

2 AI-extracted insights from 1 source — podcasts, YouTube channels, and X/Twitter accounts.

Creator sentiment — last 30 days

Not enough scored insights about Ultragenyx Pharmaceutical Inc. in the last 30 days yet.

Top creators covering Ultragenyx Pharmaceutical Inc. (RARE)

The 1 sources with the most insights about Ultragenyx Pharmaceutical Inc. on Kazuha.

Latest insights about Ultragenyx Pharmaceutical Inc. (RARE)

AI-generated insights from podcasts, YouTube videos, and X posts — ordered by most recent.

Tuesday, October 14, 2025

Neutral

The speaker holds a neutral stance, believing the stock was 'fairly valued' with no significant upside or downside at the time of analysis.

Martin Shkreli
10/14/25 +47%
Martin ShkreliYouTube252 days ago

Wednesday, July 9, 2025

Very Bearish

A bearish short-term catalyst occurred when the company did not stop its key study early for an interim analysis, which was perceived as a negative development for the trial's outcome.

Martin Shkreli
7/9/25 -12%
Martin ShkreliYouTube342 days ago

Discussed alongside Ultragenyx Pharmaceutical Inc. (RARE)

Other assets that creators frequently mention in the same content as Ultragenyx Pharmaceutical Inc..

Frequently asked

Which podcasters and creators cover Ultragenyx Pharmaceutical Inc. (RARE) the most?

The most active sources covering Ultragenyx Pharmaceutical Inc. (RARE) on Kazuha are @realmartinshkreli. Kazuha aggregates AI-extracted insights from podcasts, YouTube channels, and X/Twitter accounts.

How many insights about Ultragenyx Pharmaceutical Inc. (RARE) are on Kazuha?

Kazuha has indexed 2 AI-extracted insights about Ultragenyx Pharmaceutical Inc. (RARE) from 1 different source. New insights are added whenever a covered creator publishes a new podcast episode, video, or post.

What other assets do creators discuss alongside Ultragenyx Pharmaceutical Inc. (RARE)?

Creators covering Ultragenyx Pharmaceutical Inc. (RARE) most frequently also discuss QBTS, IONQ, PZIA, RGTI, OPEN. See the "Discussed alongside" section above for full asset pages.